The cross-linking enzyme tissue transglutaminase (tTG) participates in a variety of cellular functions. To assess its contribution to extracellular and intracellular processes during development we cloned the cDNA for chicken heart tissue transglutaminase and localized the sites of transglutaminase expression by in situ hybridization and immunohistochemistry. Compared with the chicken red blood cell transglutaminase cDNA, the heart cDNA encodes a transglutaminase with an amino-terminal truncation. The truncated enzyme retains full catalytic activity and is GTP-inhibitable. Tissue transglutaminase expression was observed in developmentally transient structures in embryonic chicken limb at day 7.5 of incubation suggesting that its expression is dynamically regulated during limb morphogenesis. The major morphogenetic events of the limb associated with transglutaminase expression were cartilage maturation during skeletal development, interdigital apoptosis, and differentiation of skeletal muscle. Maturation of the cartilage during endochondral ossification was characterized by intra-and extracellular transglutaminase accumulation in the zone of hypertrophic chondrocytes. Only intracellular enzyme could be detected in mesenchymal cells of the prospective joints, in apoptotic cells of the interdigital web, and in skeletal muscle myoblasts. An apparently constitutive expression of tissue transglutaminase was found in vascular endothelial cells corresponding to the adult expression pattern. The dynamic pattern of transglutaminase expression during morphogenesis suggests that tissue remodeling is a major trigger for transglutaminase induction.
Introduction
Transglutaminases (E.C 2.3.2.13) are Ca 2+ -dependent enzymes which introduce covalent N g-(e-glutaminyl)lysine cross-links into proteins by modifying peptide-bound glutamine residues to form stable polymeric structures.
1,2 The cross-linked proteins are involved in a diverse array of both intracellular and extracellular physiological processes. 3, 4 Some of these cross-linking reactions are catalyzed by very specialized transglutaminases that are expressed and activated in unique tissue compartments. For instance the coagulating gland of the prostate secretes a specific transglutaminase that is activated in semen and contributes to the formation of the copulatory plug in rodents. 5, 6 A distinct extracellular transglutaminase, factor XIIIa, is present in plasma and is activated during blood clotting. 7, 8 This enzyme appears to be responsible for the cross-linking of plasma and matrix proteins involved in hemostasis and wound healing. 9, 10 In addition to these extracellular transglutaminases, there are several intracellular transglutaminases that are also involved in very specialized cross-linking reactions. Keratinocyte transglutaminase 11, 12 is an intracellular enzyme that is induced during the terminal differentiation of squamous epithelial cells. Activation of this enzyme and the subsequent cross-linking of keratinocyte-specific substrate proteins lead to the formation of the cornified envelope that invests the interior of the differentiated cell. 13 In contrast to these specialized enzymes, tissue transglutaminase (tTG) is a transglutaminase that is expressed in many cells and tissues and has been implicated in both intracellular and extracellular crosslinking reactions. Studies on the localization of tTG have demonstrated that the enzyme can be found both inside cells, where it is predominantly associated with the cytoplasm 14 ± 16 as well as in the extracellular space. 17, 18 Extracellular tTG appears to be tightly bound to matrix proteins 19, 20 and has been implicated in both the crosslinking of matrix proteins 17, 21, 22 and the activation of cytokines. 23 Intracellular tTG has also been implicated in the cross-linking of cytoplasmic proteins during apoptosis 24, 25 and in GTP-dependent regulation of phospholipase C activity. 26 Much of the information on the functions of tTG has been derived from pharmacological or pathological studies, in which the expression of the enzyme has been characterized in drug-treated cells or in tissues responding to injury. In many of these situations the enzyme has appeared to be involved in tissue remodelling. 27 ± 31 To determine if tissue transglutaminase plays an equivalent role in physiological remodelling processes such as those that occur during normal development, we have characterized the patterns of expression of the enzyme in the developing chicken limb. We observed the selective expression of transglutaminase during deletion of the interdigital web by apoptosis, during the formation of the specialized extracellular matrix of the hypertrophic cartilage, and in differentiating myoblasts of the limb's skeletal muscle.
Results
Cloning and sequencing of chicken heart cDNA To characterize the expression of tTG in the developing limb of the chicken embryo we cloned its gene from a lZAP chicken heart cDNA library using a mouse macrophage tTG cDNA as a probe. We obtained a 2.8 kb partial chicken transglutaminase clone which we used to rescreen the library to yield a full length transglutaminase cDNA clone (ctg12) of 2.8 kbp (2810 nt). The nucleotide sequence of several overlapping cDNA clones identified a consensus sequence that included 33 nucleotides of 5'-untranslated DNA, an open reading frame of 2067 nucleotides encoding a protein of 689 residues and 710 nt of 3'-untranslated DNA. The translation start site conformed to a Kozak consensus sequence (ACCATGG) for translation initiation. 42 Comparison of the chicken heart cDNA sequence to that of the chicken red blood cell transglutaminase (CRBCTG) 43 revealed that both transglutaminases have very similar coding and 3'-untranslated sequences. Of the nine single nucleotide differences detected in the coding sequence, two would result in amino acid substitutions, Ala24 and Ser109 of the heart enzyme for Glu and Ile, respectively, in CRBCTG. The 5'-ends of the chicken heart and chicken red blood cell cDNAs diverged 20 nt upstream of the translation start site.
Northern blot analysis of day 13 embryonic chicken heart RNA revealed a single band of 3.2 kb when probed with ctg12 cDNA (Figure 1 ) demonstrating that there was a single species of tissue transglutaminase message in the heart.
To determine if the chicken heart cDNA encoded an active transglutaminase, COS-1 cells were transfected with an expression vector in which the chicken heart cDNA was inserted under the control of the SV40 promoter (pSG5/ cTG). Comparison of the transglutaminase activity of cells transfected with pSG5/cTG with control cells demonstrated a 40-fold increase in transglutaminase activity in the cells transfected with the transglutaminase cDNA relative to the endogenous transglutaminase level (Figure 2a ). Twohundred mM GTP-g-S inhibited the activity of the overexpressed enzyme 92.9% (not shown). Immunoblot Figure 1 Detection by Northern blotting of tissue transglutaminase mRNA in embryonic and hatchling chicken heart (a). Ten mg of total RNA prepared from the heart of day 13 embryos (lane 1), or day 4 hatchlings (lane 2) were separated on formaldehyde-agarose gel, transferred to nylon membrane and probed with a heat-denatured a-32 PdATP-labeled chicken heart transglutaminase cDNA probe. A single mRNA species of 3.2 kb was detected in the total heart RNA. 
Expression of tissue transglutaminase in the chicken limb
The goal of these studies was to characterize the expression of tissue transglutaminase in the developing chicken limb. Figure 3 compares the level of tTG in proximal and distal limb segments with the levels of the enzyme in heart, liver and brain tissues isolated from day 7.5 chicken embryos (E7.5). Both the distal and proximal limb structures contain immunoreactive tTG. The concentration of the enzyme in these tissues is comparable to that in the liver, lower than the level in the heart and considerably higher than the levels in brain tissue. At all these sites except the heart, immunoblot analysis revealed the existence of two tTG bands of very similar electrophoretic mobility.
To localize the sites of expression and accumulation of tissue transglutaminase within the structures of the developing limb, tissue sections from anterior and posterior limbs of E7.5 embryos were subject to in situ hybridization analysis with chicken heart transglutaminase cRNA probes and to immunohistochemical staining with anti-tTG antibodies (Figures 4 ± 9). In superficial sections of the limb paddle ( Figure 4 ) the hybridization signal specifically localized to the distal segments of the V-shaped interdigital regions between digits 1 and 2 and 2 and 3 of the hind limb ( Figure 4b ) and digits 2 and 3 of the forelimb (not shown). Brightfield microscopy ( Figure 4a ) of these regions showed the presence of numerous apoptotic cells in these interdigital zones. Immunochemical analysis of the same region showed immunoreactivity concentrated in clusters of apoptotic cells (Figure 5b ). Much of the immunostaining was associated with apoptotic cells engulfed by phagocytes but fragments and free-lying cells which showed characteristic apoptotic morphology both with and without nuclear remnants were also labeled. Figure 6 shows the results obtained in a section that transected the cartilaginous core of the hind limb metatarsals and phalanges. By in situ hybridization tTG mRNA could be detected in the hypertrophic chondrocytes of the prospective primary ossification centers whereas the less mature proliferating chondrocytes of the metaphyseal regions did not label (Figure 6a and b) . The epiphyseal regions of the developing bones exhibited a weak, more diffuse, hybridization signal which could be detected only after prolonged (42 week) exposure (Figure 6c and d). The epiphyseal (pre)cartilage and periarticular mesenchyme both contributed to this signal. Immunohistochemical analysis revealed that induction of the transglutaminase mRNA is paralleled by the accumulation of the enzyme ( Figure 7 ). Tissue transglutaminase accumulates both in the cytoplasm and in the extracellular matrix (Figure 7b and c). To ascertain that an artificial translocation of the enzyme Figure 3 Detection of tissue transglutaminase in E7.5 chicken tissues by immunoblotting. Tissue homogenates from E7.5 chicken embryos were separated on a 10% polyacrylamide gel, electroblotted to PVDF membrane and reacted with a goat anti-guinea pig transglutaminase antibody followed by HRPO-conjugated rabbit anti-goat IgG and chemiluminescent (ECL) detection. In limbs, liver, and brain tTG is detected as a doublet whereas in the heart a single band is seen. GPTG: 20 ng guinea pig liver transglutaminase to extracellular matrix components does not take place 20 these studies were performed on fixed tissues.
There was a low level of transglutaminase and tTG mRNA expression in the hypocellular, loose network of subepithelial mesenchyme. In the tarso-metatarsal area in situ hybridization detected a strip of very strongly labeled mesenchyme along the posterior border of the hind limb after extended autoradiographic exposure (6 ± 8 weeks), which extended onto the footplate peripheral to the marginal sinus whereas was centrally located to it at more proximal levels ( Figure 8 ). This strip of mesenchymal tissue, which could be identified in immunostained sections as well (not shown), does not bear any distinguishing morphological characteristics.
Expression of transglutaminase in muscle precursors
In situ hybridization analysis of the expression in the proximal limb also revealed specific hybridization of the cRNA probe to developing skeletal muscle (Figure 9a ). The labeling was diffuse and of low intensity. Immunochemical analysis of these structures indicated that skeletal muscle at this stage is primarily comprised of mononuclear myoblasts which arrange into bundles but do not yet fuse to form myotubes. Myoblasts with characteristic apoptotic morphology could be found in the developing muscle. These apoptotic myoblasts accumulated particularly high levels of the enzyme (Figure 9b ).
Discussion Induction of transglutaminase in apoptosis
Tissue transglutaminase accumulates in apoptotic cells induced by a variety of experimental manipulations. In cultured cells the enzyme has been identified in apoptotic hepatocytes, 25, 30 hepatoma, 25 neuroblastoma, 44 tracheal epithelial 45 and myeloid leukemia 46 cells. Accumulation of transglutaminase to high levels in vivo has been detected following lead intoxication in hepatocytes, 28 and in several organ models of atrophy-associated apoptosis. 47, 48 We have been interested whether parallel accumulations of the enzyme occur in cells undergoing normal or`physiological' programmed cell death. To address this issue we have examined the levels of tTG expression, as reflected both in accumulations of transglutaminase mRNA and protein, in the developing limb of the chicken embryo. During limb development there is a synchronous wave of cell death in the interdigital web of various vertebrates, contributing to the formation of the fingers. In the chicken embryo this peaks at embryonic day 7.5 ± 8, resulting in the separation of the fingers by day 8.5. 49 Morphologically the process is typical of apoptosis. By in situ hybridization we were able to detect accumulation of transglutaminase mRNA in the interdigital area simultaneously with the appearance of apoptotic cells and clusters. The enzyme accumulated in clusters of cells that were clearly apoptotic. It is striking that there is considerable heterogeneity in the level of enzyme detected in different clusters of apoptotic cells. While this heterogeneity might reflect technical problems associated with the penetration of antibodies into heavily cross-linked cells, we believe that it is more likely to reflect true heterogeneity in cells undergoing apoptosis. The basis of this heterogeneity, which has been observed in other models of apoptosis, 46 is not well understood at this time.
While there is extensive evidence suggesting that tTG is induced in many forms of apoptosis, it is much less clear what contribution the enzyme makes to the apoptotic program. Tissue transglutaminase catalyzes protein crosslinking. Isopeptide-crosslinked proteins accumulate to high levels in apoptotic cells 28, 29 and contribute to the stability of the fragments (apoptotic bodies) formed during apoptosis. TTG is also a GTP-binding protein 50 ± 52 that has been shown to regulate the activity of membrane-bound phospholipase C. 26, 53 It is possible that the induction and activation of the enzyme contributes to increased phospholipase activity in the apoptotic cells that may, in turn, facilitate membrane blebbing and cellular fragmentation. Both activities of tTG may contribute to its function in apoptotic interdigital cells.
Although our studies have concentrated on the expression of tTG in interdigital mesenchymal cells, apoptosis can be identified in other tissues involved in limb morphogen- esis. 54 Apoptotic muscle cells have been described during skeletal muscle development. 55 We observed apoptotic myoblasts during early development of striated muscle characterized by migration and fusion of the myoblasts to form myotubes. In the day 7.5 embryonic limb apoptotic myoblasts were scattered in developing leg and thigh skeletal muscle. The cytoplasm of many of these isolated apoptotic myoblasts also accumulated transglutaminase protein indicating that the induction of the enzyme is common to various forms of physiological apoptosis.
The localization of expression of the endogenous tissue transglutaminase gene in the interdigital web of the day 7.5 chick embryo is identical to that observed in E13.5 mouse embryos transgenic for a 4 kb segment of the mouse tTG promoter/b-galactosidase construct. 56 
Induction of transglutaminase during chondrogenesis
Skeletal development in the limb is initiated by the condensation of precartilage mesenchymal cells, followed by differentiation to form a cartilaginous template which, in turn, is replaced by endochondral bone. We found by in situ hybridization that the precartilaginous mesenchyme, the hypertrophic chondrocytes, and the surrounding perichondrium expressed transglutaminase mRNA. The association of transglutaminase with hypertrophic cartilage is similar to its pattern of expression in the mammalian growth plate, 57 the structure responsible for the postnatal growth of long bones. Aeschlimann et al. 57 have demonstrated in the epiphyseal cartilage of newborn rats that increasing expression of transglutaminase parallels the maturation of the cartilage. Tissue transglutaminase synthesized by these maturing chondrocytes has been shown to catalyze the covalent cross-linking of extracellular matrix proteins, 58, 59 thereby contributing to the stability of the cartilaginous matrix. Histological analysis of hypertrophic cartilage from formaldehyde-fixed embryonic chicken limbs demonstrated that transglutaminase, as well as accumulating intracellularly, was also deposited in the inter-territorial cartilage matrix. The use of fixed tissue for cryosectioning precludes the possibility of the artefactual translocation of the enzyme from the cytoplasm to components of the extracellular matrix. The deposition of transglutaminase in the extracellular matrix precedes the destruction of the hypertrophic chondrocytes and it is likely to represent active secretion from viable cells. The observation of transglutaminase expression in the precartilage of the epiphysis and (pre)articular mesenchyme indicates that, in addition to ossification, transglutaminase activity might contribute to joint formation. It is interesting to note that transglutaminase expression apparently is associated with specific phases of skeletal development, with striking downregulation in the intervening phases such as the proliferating cartilage phase. The coordinate regulation of enzyme and potential substrates is a possible explanation since specific sets of proteins and patterns of their expression are associated with anatomically or developmentally distinct parts of the skeleton. 60 The widespread expression of tissue transglutaminase during organogenesis in the embryo contrasts sharply with its limited expression in mesenchymal tissues of the adult organism. 15 The re-appearance of tTG expression during tissue repair and mesenchymal proliferation in adult tissues such as would healing, 27 the progression of atherosclerotic plaques, 61 or within fibrohistiocytic tumors 62 indicates that the enzyme is commonly activated in the context of tissue remodelling.
Materials and methods

Materials
Chicken heart cDNA library cloned into lZAP, pBluescript SK II, and pSG5 were purchased from Stratagene (La Jolla, CA, USA). T7 RNA polymerase, RQ1 DNase, T4 polynucelotide kinase, and Riboprobe Gemini II in vitro transcription kit were from Promega Biotec (Madison, WI, USA). T3 RNA polymerase, Sequenase sequencing kit, and BSA were from USB (Cleveland, OH, USA); S1 nuclease and RNase A from Worthington (Freehold, NJ, USA); [a- 35 
Tissue collection and processing
Eggs of White Leghorn chickens were incubated in a ventilated incubator at 388C. Tissues of chicken embryos were collected at day 7.5 of incubation (E 7.5, HH stage 32, 32 and fixed in 4% paraformaldehyde at room temperature for 4 h for immunohistochemistry or at 48C for 2 h for in situ hybridization experiments. Limbs were washed at 48C overnight in PBS, embedded in O.C.T. compound, snap-frozen in isopentane chilled with dry ice and cut on a cryostat (Minotome, Boston, MA, USA) at 4 ± 6 mm. Sections were picked up on silanized slides.
Antibody
The affinity purified goat anti-guinea pig liver transglutaminase antibody 33 detects tTG in cell or tissue homogenates from various sources as a single band in Western blotting experiments.
Immunoblotting
Tissue samples from 7.5 ± 8-day chicken embryos were collected and homogenized in 20 mM Tris/1 mM EDTA, pH 7.5 by mincing followed by sonication on ice. Protein concentration of the homogenates was determined by the Bio-Rad Protein Assay kit (Bio-Rad, Hercules, CA, USA) with BSA as the standard. Lysates were denatured by boiling for 2 min in SDS sample buffer containing 20 mM Tris, pH 7.5, 1% SDS, 0.75 M 2-mercaptoethanol, 2.5% sucrose, and 0.001% bromophenol blue. Solubilized extracts were fractionated by electrophoresis on a 10% polyacrylamide gel and electroblotted onto Immobilon-P membrane (Millipore, Bedford, MA, USA). Filters were blocked in a solution of 1% non-fat dry milk, 1% BSA, 50 mM Tris, pH 7.5, 0.5 M NaCl, 0.1 polyvinylpyrrolidone, 0.1% Ficoll 400 for 1 h with rocking. Affinity purified goat anti-guinea pig liver transglutaminase antibody was applied at 1 mg/ml in the above blocking solution for 2 h at room temperature. Filters were washed six times for 5 min in 1% non-fat dry milk, 20 mM Tris, pH 7.5, 0.5 M NaCl, 0.1% Triton X-100 (Sigma). The secondary antibody was a HRP-conjugated affinity purified rabbit antigoat IgG (Sigma A5420) applied at a dilution of 1 : 10,000 for 1 h in blocking solution, following which the filters were washed as above, and antigen-antibody complexes were identified by chemiluminescent detection using the ECL kit (Amersham Life Sciences, Inc., Arlington Heights, IL, USA) according to the manufacturer's instructions.
Immunohistochemistry
Cryostat sections of paraformaldehyde-fixed tissues were used. Sections were air-dried for 3 h at room temperature. Endogenous peroxidase activity was blocked by 0.1 M periodic acid treatment for 5 min. Sections were covered with a mixture of 1% gelatin ± 20% normal rabbit serum for 20 min at room temperature. Sections were incubated with affinity purified goat anti-guinea pig liver transglutaminase at 5 mg/ml in 1% gelatin ± 20% normal rabbit serum overnight at room temperature. Control slides were incubated with a 1 : 1000 dilution of the IgG fraction of the preimmune serum. Washing was in Tris-buffered saline for 3610 min. Biotinylated rabbit anti-goat IgG was applied at 1 : 150 dilution in 1% gelatin ± 20% normal rabbit serum for 45 min at room temperature. Washing was as above, followed by avidin ± biotinylated peroxidase complex (Vectastain Elite kit, Vector) according to the manufacturer's instructions. The immunoreaction was visualized by 0.05% DAB ± 0.001% H 2 O 2 . Sections were counterstained with Mayer's hemalum, dehydrated and mounted in Permount.
Transglutaminase assay
To assess enzymatic activity of tTG we used the filter paper assay of Lorand and co-workers. 34 This assay measures the covalent conjugation of the amine substrate [ 3 H]putrescine by the transglutaminase of the cell homogenate to N,N-dimethylated casein in the presence of calcium ions. GTP-inhibition was tested in the presence of 200 mM of the non-hydrolyzable GTP-analogue guanosine 5'O-(3-thiotriphosphate) (GTP-g-S) (Sigma) and 1 mM Ca 2+ .
Cloning and sequencing of chicken heart tissue transglutaminase cDNA
An adult chicken heart cDNA library, cloned into the EcoRI site of the lZAP vector, was obtained from Stratagene (La Jolla, CA, USA). Approximately 5610 5 plaques were screened using a 1.5 kbp partial cDNA clone of mouse tTG as probe. Prehybridization, hybridization, and autoradiography were according to established protocols. 35 Fourteen clones gave positive signal upon the third round of screening. Plasmid subclones in pBluescript were obtained, and linearized plasmids were used in a Southern blotting experiment to determine insert size. Of the two positive clones ctg6a1, a clone containing a 2.8 kbp insert, was used for subsequent hybridization experiments. Partial sequencing of this clone showed that it did not include a translational start site. Using an 0.4 kbp long 5' EcoRI ± StuI fragment of this clone we rescreened the library to obtain a clone which contained the whole coding sequence. Using high stringency hybridization and washing conditions 12 positive clones out of 6610 5 were found. One of these (ctg12) contained a larger EcoRI ± StuI fragment than the insert used for screening. Sequencing of chicken transglutaminase cDNAs was carried out by the dideoxy chain termination method 36 using the Sequenase sequencing kit (USB, Cleveland, OH, USA) or by automated sequencing on an ABI model 373 sequencer (Foster City, CA, USA) using dye terminator chemistry according to the manufacturer's protocol. The sequence was derived from partial sequencing of ctg12, ctg6a.1, and overlapping subclones thereof but is contained in its entirely in clone ctg12. The obtained sequence was compared to the human tTG sequence by the NUCALN and PRTALN programs of Wilbur and Lipman 37 or by the Geneworks software (Intelligenetics, Inc., Campbell, CA, USA).
RNA blotting
Total cellular RNA from hearts of embryonic chickens or hatchlings was prepared by the guanidine isothiocyanate method 38 followed by density gradient centrifugation through 5.7 M CsCl for 18 h at 35 000 r.p.m. in a Beckman SW 50.1 rotor. Ten mg of total RNA was loaded unto a 1% agarose ± 2.2 M formaldehyde gel and run at 60 V for 3 h in MOPS running buffer. RNA was transferred to nylon membrane (Stratagene) by capillary transfer in 106SSC overnight, and immobilized by UV cross-linking (Stratalinker, Stratagene). Prehybridization and hybridization were for 3 h and 12 h, respectively, using 10 6 c.p.m./ml of the random-primed labeled chicken transglutaminase cDNA probe. Filters were washed in 16SSC ± 0.1% SDS, 2615 min at room temperature, followed by 0.16SSC ± 0.1% SDS, 2615 min at 608C. Filters were exposed against Kodak Xomat film at 7708C for 12 ± 36 h.
In situ hybridization
[ 35 S]-labeled RNA probes were used for in situ hybridization. Complementary RNAs were prepared by in vitro transcription using the Riboprobe Gemini II kit. pBluescript containing the 2.8 kbp insert (clone 6a.1) was linearized with either XbaI (to obtain antisense transcript) or SalI (to obtain sense transcript) and riboprobes were synthesized according to the manufacturer's protocol using either T3 (USB) or T7 (Promega) RNA polymerases and [a- 35 S]UTP. Following in vitro transcription the DNA template was digested with 1 U of RQ1 DNase (Promega) at 378C for 5 min. Probe size was reduced to approximately 150 nt by limited alkaline hydrolysis at 608C. 39 Unincorporated label was removed by spinning the probes through Sephadex G 50 column (Boehringer Mannheim, Indianapolis, IN, USA) equilibrated with 20 mM Tris, pH 7.6/26SSC/10 mM DTT.
Limbs of day 7.5 chicken embryos with or without fixation in 4% paraformaldehyde at 48C for 2 h, were embedded in O.C.T. compound and snap-frozen in isopentane chilled with dry ice. Sections were cut on the cryostat at 4 ± 6 mm nominal thickness, picked up on alkoxysilane-coated slides, briefly air-dried, and fixed with 4% paraformaldehyde in PBS for 5 min. Tissue pretreatments and hybridization were done according to Harper and Marselle. 40 Slides were air-dried and exposed at 48C for 6 ± 8 weeks in the presence of desiccant. Slides were developed with Kodak Dektol developer at 158C for 2 min and fixed in Kodak rapid fixer.
Transfection
Full length ctg12 was inserted into the eukaryotic expression vector pSG5 in either orientation. Using these constructs transient transfection of COS-1 cells was carried out by the DEAE-dextran procedure. 41 Cells were harvested 72 h after transfection and aliquots of the cell lysate were assayed for transglutaminase activity in the presence or absence of 200 mM of GTP-g-S, or subjected to immunoblotting.
